Årsrapport34209936Grant Thornton, Godkendt RevisionspartnerselskabStockholmsgade, 452100, København Ø2021-10-012022-09-302022-10-012023-12-3142208825The Binding Site Danmark ApSBredgade301260København K2021-02-26Grant Thornton, Godkendt Revisionspartnerselskab34209936Kasper Sone Randrupstatsautoriseret revisormne36175Stockholmsgade452100København ØDanmark+45 33 110 220info@dk.gt.com2024-07-04Petrus Thomas Adrianus van der ZandeRegnskabsklasse BAndre erklæringer uden sikkerhedCaseWare fra Revisorgruppen DanmarkanpartshaverneKøbenhavn2024-07-04København K2024-07-045392584-6200202615903366425-6200138886057603504735-620076780002736935-62002736935-62001597710159771038157700400004155038557704155036796920769523341550769523341550040000400002718235-187002758235213006820682085108125002786246775076780001297162049363162025049369982025076952334155017921190231295027450202615902022203540576040000400004000040000-18700-125002736935-62002718235-18700Today, the Executive Board has approved the annual report of The Binding Site Danmark ApS for the financial year 1 October 2022 - 31 December 2023. The annual report has been prepared in accordance with the Danish Financial Statements Act. We consider the chosen accounting policy to be appropriate, and in our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 October 2022 – 31 December 2023. The Executive Board consider the conditions for audit exemption of the 2022/23 financial statements to be met. Further, in our opinion, the Management's review gives a true and fair review of the matters discussed in the Management's review. We recommend that the annual report be approved at the Annual General Meeting. Petrus Thomas Adrianus van der ZandeJouni Olavi SallinenWe have compiled the financial statements of The Binding Site Danmark ApS for the financial year 1 October 2022 - 31 December 2023 based on the company's bookkeeping and on information you have provided. These financial statements comprise a summary of significant accounting policies, income statement, balance sheet og statement of changes in equity. We performed this compilation engagement in accordance with International Standard on Related Services 4410 (Revised), Compilation Engagements. We have applied our expertise in accounting and financial reporting to assist Management in the preparation and presentation of these financial statements in accordance with the Danish Financial Statements Act. We have complied with relevant requirements under the Danish Act on Approved Auditors and Audit Firms and International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) including principles of integrity, objectivity, professional competence and due care. These financial statements and the accuracy and completeness of the information used to compile them are your responsibility. Since a compilation engagement is not an assurance engagement, we are not required to verify the accuracy or completeness of the information you provided to us to compile these financial statements. Accordingly, we do not express an audit opinion or a review conclusion on whether these financial statements are prepared in accordance with the Danish Financial Statements Act. The principal activities of the company The principal activities of the company is wholesale of medical and hospital articles. Development in activities and financial matters The gross profit for the year totals DKK 5.392.584 against DKK -6.200 last year. Income or loss from ordinary activities after tax totals DKK 2.736.935 against DKK -6.200 last year. Management considers the net profit or loss for the year satisfactory. The annual report for The Binding Site Danmark ApS has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises. The accounting policies are unchanged from the previous year, and the annual report is presented in DKK. The accounting period has been changed in the current financial year and comprises the period 1 October 2022 – 31 December 2023. The comparative figures in the income statement comprise the period 1 October 2021 – 30 September 2022. Gross profit Gross profit comprises the revenue, changes in inventories of finished goods and external costs. Revenue is recognised in the income statement if delivery and passing of risk to the buyer have taken place before the end of the year and if the income can be determined reliably and inflow is anticipated. Revenue is measured at the fair value of the consideration promised exclusive of VAT and taxes and less any discounts relating directly to sales. Cost of sales comprises costs concerning purchase of raw materials and consumables less discounts and changes in inventories. Other external costs comprise costs incurred for administration. Staff costs Staff costs include salaries and wages, including holiday allowances, pensions, and other social security costs, etc., for staff members. Financial income and expenses Financial income and expenses are recognised in the income statement with the amounts concerning the financial year. Financial income and expenses comprise interest income and expenses, financial expenses from financial leasing, realised and unrealised capital gains and losses relating to securities, debt and transactions in foreign currency, amortisation of financial assets and liabilities as well as surcharges and reimbursements under the advance tax scheme, etc. Tax on net profit or loss for the year Tax for the year comprises the current income tax for the year and changes in deferred tax and is recognised in the income statement with the share attributable to the net profit or loss for the year and directly in equity with the share attributable to entries directly in equity. Inventories Inventories are measured at cost according to the FIFO method. In cases when the net realisable value of the inventories is lower than the cost, the latter is written down for impairment to this lower value. Costs of goods for resale, raw materials, and consumables comprise acquisition costs plus delivery costs. Receivables Receivables are measured at amortised cost, which usually corresponds to nominal value. Cash and cash equivalents Cash and cash equivalents comprise cash at bank and on hand. Income tax and deferred tax Current tax liabilities and current tax receivable are recognised in the statement of financial position as calculated tax on the taxable income for the year, adjusted for tax of previous years' taxable income and for tax paid on account. Deferred tax is measured on the basis of temporary differences in assets and liabilities with a focus on the statement of financial position. Deferred tax is measured at net realisable value. Deferred tax is measured based on the tax rules and tax rates applying under the legislation prevailing in the respective countries on the reporting date when the deferred tax is expected to be released as current tax. Changes in deferred tax due to changed tax rates are recognised in the income statement, except for items included directly in the equity. Deferred tax assets, including the tax value of tax losses allowed for carryforward, are recognised at the value at which they are expected to be realisable, either by settlement against tax of future earnings or by set-off in deferred tax liabilities within the same legal tax unit. Any deferred net tax assets are measured at net realisable value. Liabilities other than provisions Other liabilities concerning payables to suppliers, group enterprises, and other payables are measured at amortised cost which usually corresponds to the nominal value. 422088252022-10-012023-12-31422088252021-10-012022-09-30422088252022-09-30422088252023-12-31422088252022-10-012023-12-312422088252022-10-012023-12-311422088252022-10-012023-12-311422088252022-10-01e:ContributedCapitalMember422088252023-12-31e:ContributedCapitalMember422088252022-10-01e:RetainedEarningsMember422088252022-10-012023-12-31e:RetainedEarningsMember422088252023-12-31e:RetainedEarningsMember422088252021-10-01e:ContributedCapitalMember422088252022-09-30e:ContributedCapitalMember422088252021-10-01e:RetainedEarningsMember422088252021-10-012022-09-30e:RetainedEarningsMember422088252022-09-30e:RetainedEarningsMemberiso4217:DKKxbrli:pure